PTGS2 and colonic neoplasm: In 2006, Strillacci and colleagues applied a RNA interference technique to knock down the overexpressed COX-2 in colon cancer cell lines (HT-29) and found that this COX-2 knockdown did not exert any effect on HT-29 cell proliferation [30].